These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35919496)

  • 1. Safety of the use of gold nanoparticles conjugated with proinsulin peptide and administered by hollow microneedles as an immunotherapy in type 1 diabetes.
    Tatovic D; McAteer MA; Barry J; Barrientos A; Rodríguez Terradillos K; Perera I; Kochba E; Levin Y; Dul M; Coulman SA; Birchall JC; von Ruhland C; Howell A; Stenson R; Alhadj Ali M; Luzio SD; Dunseath G; Cheung WY; Holland G; May K; Ingram JR; Chowdhury MMU; Wong FS; Casas R; Dayan C; Ludvigsson J
    Immunother Adv; 2022; 2(1):ltac002. PubMed ID: 35919496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting proinsulin to local immune cells using an intradermal microneedle delivery system; a potential antigen-specific immunotherapy for type 1 diabetes.
    Arikat F; Hanna SJ; Singh RK; Vilela L; Wong FS; Dayan CM; Coulman SA; Birchall JC
    J Control Release; 2020 Jun; 322():593-601. PubMed ID: 32087298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjugation of a peptide autoantigen to gold nanoparticles for intradermally administered antigen specific immunotherapy.
    Dul M; Nikolic T; Stefanidou M; McAteer MA; Williams P; Mous J; Roep BO; Kochba E; Levin Y; Peakman M; Wong FS; Dayan CM; Tatovic D; Coulman SA; Birchall JC;
    Int J Pharm; 2019 May; 562():303-312. PubMed ID: 30910633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microneedle delivery of autoantigen for immunotherapy in type 1 diabetes.
    Zhao X; Birchall JC; Coulman SA; Tatovic D; Singh RK; Wen L; Wong FS; Dayan CM; Hanna SJ
    J Control Release; 2016 Feb; 223():178-187. PubMed ID: 26739548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intradermal delivery of vaccine nanoparticles using hollow microneedle array generates enhanced and balanced immune response.
    Niu L; Chu LY; Burton SA; Hansen KJ; Panyam J
    J Control Release; 2019 Jan; 294():268-278. PubMed ID: 30572036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using gold nanoparticles for enhanced intradermal delivery of poorly soluble auto-antigenic peptides.
    Singh RK; Malosse C; Davies J; Malissen B; Kochba E; Levin Y; Birchall JC; Coulman SA; Mous J; McAteer MA; Dayan CM; Henri S; Wong FS
    Nanomedicine; 2021 Feb; 32():102321. PubMed ID: 33184020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic and immune effects of immunotherapy with proinsulin peptide in human new-onset type 1 diabetes.
    Alhadj Ali M; Liu YF; Arif S; Tatovic D; Shariff H; Gibson VB; Yusuf N; Baptista R; Eichmann M; Petrov N; Heck S; Yang JHM; Tree TIM; Pujol-Autonell I; Yeo L; Baumard L; Stenson R; Howell A; Clark A; Boult Z; Powrie J; Adams L; Wong FS; Luzio S; Dunseath G; Green K; O'Keefe A; Bayly G; Thorogood N; Andrews R; Leech N; Joseph F; Nair S; Seal S; Cheung H; Beam C; Hills R; Peakman M; Dayan CM
    Sci Transl Med; 2017 Aug; 9(402):. PubMed ID: 28794283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide-for type 1 diabetes.
    Nikolic T; Zwaginga JJ; Uitbeijerse BS; Woittiez NJ; de Koning EJ; Aanstoot HJ; Roep BO
    Lancet Diabetes Endocrinol; 2020 Jun; 8(6):470-472. PubMed ID: 32723484
    [No Abstract]   [Full Text] [Related]  

  • 9. Intradermal vaccination with hollow microneedles: A comparative study of various protein antigen and adjuvant encapsulated nanoparticles.
    Du G; Hathout RM; Nasr M; Nejadnik MR; Tu J; Koning RI; Koster AJ; Slütter B; Kros A; Jiskoot W; Bouwstra JA; Mönkäre J
    J Control Release; 2017 Nov; 266():109-118. PubMed ID: 28943194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model.
    Gibson VB; Nikolic T; Pearce VQ; Demengeot J; Roep BO; Peakman M
    Clin Exp Immunol; 2015 Dec; 182(3):251-60. PubMed ID: 26206289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coated and Hollow Microneedle-Mediated Intradermal Immunization in Mice with Diphtheria Toxoid Loaded Mesoporous Silica Nanoparticles.
    Du G; Woythe L; van der Maaden K; Leone M; Romeijn S; Kros A; Kersten G; Jiskoot W; Bouwstra JA
    Pharm Res; 2018 Aug; 35(10):189. PubMed ID: 30105542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Customized cell-based treatment options to combat autoimmunity and restore beta-cell function in type 1 diabetes mellitus: current protocols and future perspectives.
    Fändrich F; Ungefroren H
    Adv Exp Med Biol; 2010; 654():641-65. PubMed ID: 20217518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold Nanoparticles Conjugated with Glycopeptides for Lectin Detection and Imaging on Cell Surface.
    Tsutsumi H; Shirai T; Ohkusa H; Mihara H
    Protein Pept Lett; 2018; 25(1):84-89. PubMed ID: 29256341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hollow microneedle-mediated intradermal delivery of model vaccine antigen-loaded PLGA nanoparticles elicits protective T cell-mediated immunity to an intracellular bacterium.
    de Groot AM; Du G; Mönkäre J; Platteel ACM; Broere F; Bouwstra JA; Sijts AJAM
    J Control Release; 2017 Nov; 266():27-35. PubMed ID: 28917531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, tissue distribution and safety of gold nanoparticle/PKC Delta inhibitor peptide hybrid in rats.
    Konoeda H; Takizawa H; Gower A; Zhao M; Adeyi OA; Liu M
    Nanotoxicology; 2020 Apr; 14(3):341-354. PubMed ID: 31852291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes.
    Norman JJ; Brown MR; Raviele NA; Prausnitz MR; Felner EI
    Pediatr Diabetes; 2013 Sep; 14(6):459-65. PubMed ID: 23517449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive evaluation of microneedle-based intradermal adalimumab delivery vs. subcutaneous administration: results of a randomized controlled clinical trial.
    Jacobse J; Ten Voorde W; Tandon A; Romeijn SG; Grievink HW; van der Maaden K; van Esdonk MJ; Moes DJAR; Loeff F; Bloem K; de Vries A; Rispens T; Wolbink G; de Kam M; Ziagkos D; Moerland M; Jiskoot W; Bouwstra J; Burggraaf J; Schrier L; Rissmann R; Ten Cate R
    Br J Clin Pharmacol; 2021 Aug; 87(8):3162-3176. PubMed ID: 33403697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-mediated targeting of autoantigen peptide to cross-presenting liver sinusoidal endothelial cells protects from CD8 T-cell-driven autoimmune cholangitis.
    Carambia A; Gottwick C; Schwinge D; Stein S; Digigow R; Şeleci M; Mungalpara D; Heine M; Schuran FA; Corban C; Lohse AW; Schramm C; Heeren J; Herkel J
    Immunology; 2021 Apr; 162(4):452-463. PubMed ID: 33346377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate Cancer Targeted X-Ray Fluorescence Imaging via Gold Nanoparticles Functionalized With Prostate-Specific Membrane Antigen (PSMA).
    Hara D; Tao W; Totiger TM; Pourmand A; Dogan N; Ford JC; Shi J; Pollack A
    Int J Radiat Oncol Biol Phys; 2021 Sep; 111(1):220-232. PubMed ID: 33964351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Green synthesis of gold nanoparticles for immune response regulation: Mechanisms, applications, and perspectives.
    Cai F; Li S; Huang H; Iqbal J; Wang C; Jiang X
    J Biomed Mater Res A; 2022 Feb; 110(2):424-442. PubMed ID: 34331516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.